Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chams

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Dermatology|February 17, 2015
Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgarisM H Javanbakht, M Djalali, M Daneshpazhooh, et al.
Advances in Experimental Medicine and Biology|August 16, 2003
Origin and outcome of macular edema in Behçet's diseaseH Chams, A Lashei, A Sadeghi-Tari, et al.
Advances in Experimental Medicine and Biology|August 16, 2003
Recent epidemiological data on Behçet's disease in Iran. The 2001 surveyF Shahram, F Davatchi, A Nadji, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2013
Pemphigus vulgaris-associated Kaposi's sarcoma: response to paclitaxel and review of the literatureK Balighi, M Daneshpazhooh, N Aghazadeh, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2007
Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activityM Daneshpazhooh, C Chams-Davatchi, A Khamesipour, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2007
Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trialM N Tabrizi, C Chams-Davatchi, N Esmaeeli, et al.
Annales De Dermatologie Et De Venereologie|April 9, 2002
[Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris]C Chams-Davatchi, R Nonahal Azar, M Daneshpazooh, et al.
Clinical and Experimental Dermatology|February 18, 2015
Loss of normal anagen hair in pemphigus vulgarisM Daneshpazhooh, H R Mahmoudi, S Rezakhani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2012
Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgarisC Chams-Davatchi, A Mortazavizadeh, M Daneshpazhooh, et al.
European Journal of Clinical Nutrition|August 24, 2017
Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trialH Mohammadi, M Djalali, M Daneshpazhooh, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Dermatology|February 17, 2015
Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgarisM H Javanbakht, M Djalali, M Daneshpazhooh, et al.
Advances in Experimental Medicine and Biology|August 16, 2003
Origin and outcome of macular edema in Behçet's diseaseH Chams, A Lashei, A Sadeghi-Tari, et al.
Advances in Experimental Medicine and Biology|August 16, 2003
Recent epidemiological data on Behçet's disease in Iran. The 2001 surveyF Shahram, F Davatchi, A Nadji, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2013
Pemphigus vulgaris-associated Kaposi's sarcoma: response to paclitaxel and review of the literatureK Balighi, M Daneshpazhooh, N Aghazadeh, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2007
Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activityM Daneshpazhooh, C Chams-Davatchi, A Khamesipour, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2007
Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trialM N Tabrizi, C Chams-Davatchi, N Esmaeeli, et al.
Annales De Dermatologie Et De Venereologie|April 9, 2002
[Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris]C Chams-Davatchi, R Nonahal Azar, M Daneshpazooh, et al.
Clinical and Experimental Dermatology|February 18, 2015
Loss of normal anagen hair in pemphigus vulgarisM Daneshpazhooh, H R Mahmoudi, S Rezakhani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2012
Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgarisC Chams-Davatchi, A Mortazavizadeh, M Daneshpazhooh, et al.
European Journal of Clinical Nutrition|August 24, 2017
Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trialH Mohammadi, M Djalali, M Daneshpazhooh, et al.
Pageof 5